Immunoshield Therapeutics Inc.
Publicly observedChandler, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Chandler | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Immunoshield Therapeutics Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | F4L8SL24M5D5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant4 Aug 2023Publicly observed
NIH SBIR/STTR award: Hydrogel injection molded islet macroencapsulation devices to treat diabetes in a non-human primate model
USD 935,197.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant4 Aug 2023Publicly observed
NIH SBIR/STTR award: Hydrogel injection molded islet macroencapsulation devices to treat diabetes in a non-human primate model
USD 913,868.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.